Variant report
Variant | nsv961497 |
---|---|
Chromosome Location | chr2:114428065-114429638 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:114428227-114428277 | CMK | blood: | n/a |
2 | chr2:114428227-114428277 | MCF-7 | breast: | n/a |
3 | chr2:114428227-114428277 | ECC-1 | luminal epithelium: | n/a |
4 | chr2:114428227-114428277 | HCPEpiC | choroid plexus: | n/a |
5 | chr2:114428227-114428277 | SK-N-SH | brain: | n/a |
6 | chr2:114428227-114428277 | HL-60 | blood: | n/a |
7 | chr2:114428227-114428277 | HRPEpiC | eye: | n/a |
8 | chr2:114428227-114428277 | NT2-D1 | testis: | n/a |
9 | chr2:114428227-114428277 | SK-N-SH_RA | brain: | n/a |
10 | chr2:114428227-114428277 | PrEC | prostate: | n/a |
11 | chr2:114428227-114428277 | U87 | brain: | n/a |
12 | chr2:114428227-114428277 | HEEpiC | esophagus: | n/a |
13 | chr2:114428227-114428277 | GM12891 | blood: | n/a |
14 | chr2:114428227-114428277 | MCF10A-Er-Src | breast: | n/a |
15 | chr2:114428227-114428277 | HepG2 | liver: | n/a |
16 | chr2:114428227-114428277 | HNPCEpiC | eye: | n/a |
17 | chr2:114428227-114428277 | RPTEC | kidney: | n/a |
18 | chr2:114428227-114428277 | Caco-2 | colon: | n/a |
19 | chr2:114428227-114428277 | BE2_C | brain: | n/a |
20 | chr2:114428227-114428277 | HMEC | breast: | n/a |
21 | chr2:114428227-114428277 | GM06990 | blood: | n/a |
22 | chr2:114428227-114428277 | ProgFib | skin: | n/a |
23 | chr2:114428227-114428277 | HIPEpiC | eye: | n/a |
24 | chr2:114428227-114428277 | AG10803 | skin: | n/a |
25 | chr2:114428227-114428277 | PANC-1 | pancreas: | n/a |
26 | chr2:114428227-114428277 | HUVEC | blood vessel: | n/a |
27 | chr2:114428227-114428277 | HCM | heart: | n/a |
28 | chr2:114428227-114428277 | AG04449 | skin: | fetal |
29 | chr2:114428227-114428277 | Hela-S3 | cervix: | n/a |
30 | chr2:114428227-114428277 | GM12892 | blood: | n/a |
31 | chr2:114428227-114428277 | T-47D | breast: | n/a |
32 | chr2:114428227-114428277 | AG09319 | gingival: | n/a |
33 | chr2:114428227-114428277 | GM12878 | blood: | n/a |
34 | chr2:114428227-114428277 | NHBE | bronchial: | n/a |
35 | chr2:114428227-114428277 | LNCaP | prostate: | n/a |
36 | chr2:114428227-114428277 | Jurkat | blood: | n/a |
37 | chr2:114428227-114428277 | AG09309 | skin: | n/a |
38 | chr2:114428227-114428277 | H1-hESC | embryonic stem cell: | embryo |
39 | chr2:114428227-114428277 | ovcar-3 | ovarian: | n/a |
40 | chr2:114428227-114428277 | AG04450 | lung: | fetal |
41 | chr2:114428227-114428277 | BJ | skin: | n/a |
42 | chr2:114428227-114428277 | HAEpiC | amniotic membrane: | n/a |
43 | chr2:114428227-114428277 | NH-A | brain: | n/a |
44 | chr2:114428227-114428277 | HPAEpiC | pulmonary alveolar: | n/a |
45 | chr2:114428227-114428277 | Hepatocyte | liver: | n/a |
46 | chr2:114428227-114428277 | A549 | lung: | n/a |
47 | chr2:114428227-114428277 | K562 | blood: | n/a |
48 | chr2:114428227-114428277 | SKMC | muscle: | n/a |
49 | chr2:114428227-114428277 | HCF | heart: | n/a |
50 | chr2:114428227-114428277 | GM19239 | blood: | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RABL2A-1 | chr2:114429415-114429503 | XLOC_001633 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000175509 | TF binding region |
ENSG00000175509 | CpG island |
OSBP | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534442630 | chr2:114428080-114428081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554006606 | chr2:114428099-114428100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566769433 | chr2:114428107-114428108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113726445 | chr2:114428159-114428160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555582419 | chr2:114428164-114428165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372467491 | chr2:114428195-114428196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551526884 | chr2:114428240-114428241 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs7576319 | chr2:114428258-114428259 | Weak transcription | CpG island | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs537938493 | chr2:114428261-114428262 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs188727939 | chr2:114428270-114428271 | Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs577790840 | chr2:114428356-114428357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540544556 | chr2:114428374-114428375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs13028979 | chr2:114428418-114428419 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs573561574 | chr2:114428597-114428598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114288195 | chr2:114428636-114428637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562338485 | chr2:114428637-114428638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs148934997 | chr2:114428644-114428645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs551479509 | chr2:114428658-114428659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143645150 | chr2:114428665-114428666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6726595 | chr2:114428705-114428706 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs370716436 | chr2:114428717-114428718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs191907591 | chr2:114428734-114428735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148281984 | chr2:114428738-114428739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12619214 | chr2:114428769-114428770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549398999 | chr2:114428790-114428791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568894877 | chr2:114428801-114428802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs573932371 | chr2:114428822-114428823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13024574 | chr2:114428843-114428844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs186633454 | chr2:114428848-114428849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577830112 | chr2:114428885-114428886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs191442100 | chr2:114428887-114428888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs142883809 | chr2:114428913-114428914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183647271 | chr2:114428917-114428918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542938995 | chr2:114428937-114428938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs562535077 | chr2:114428941-114428942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576080716 | chr2:114428944-114428945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536675702 | chr2:114429040-114429041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545140914 | chr2:114429041-114429042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564934109 | chr2:114429122-114429123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs187792734 | chr2:114429136-114429137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547615619 | chr2:114429189-114429190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12616463 | chr2:114429202-114429203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs3811060 | chr2:114429211-114429212 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs530036338 | chr2:114429304-114429305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192953670 | chr2:114429419-114429420 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs573252525 | chr2:114429452-114429453 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs536903243 | chr2:114429462-114429463 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs185112516 | chr2:114429484-114429485 | Bivalent Enhancer Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs13003858 | chr2:114429542-114429543 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs571457186 | chr2:114429545-114429546 | Bivalent Enhancer Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Neuroticism | 17667963 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:114424800-114433400 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
2 | chr2:114429400-114430600 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
3 | chr2:114429400-114430600 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr2:114429400-114430600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr2:114429400-114430800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr2:114429400-114434800 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
7 | chr2:114429600-114430000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
8 | chr2:114429600-114430200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr2:114429600-114430400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr2:114429600-114430600 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |
11 | chr2:114429600-114430600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
12 | chr2:114429600-114430600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr2:114429600-114431000 | Enhancers | HUES48 Cell Line | embryonic stem cell |